Midgard Science

Labs / CDMO: development & manufacturing

IGI

New York, NY, United States · iginnovate.com

On your own

Free. Their own form.

Contact IGI directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

IGI is a global, clinical-stage biotechnology company focused on developing innovative biologics in oncology. It is headquartered in New York, NY, with additional centers of innovation in Switzerland and India. The company is advancing multispecific antibody programs for hematological malignancies and solid tumors.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Multispecific biologics discovery and development

    Develops novel first-in-class multispecific biologics for oncology programs from discovery through clinical development.

  • Protein engineering platform development

    Uses its BEAT technology platform to engineer full-length multispecific antibodies with manufacturability in mind.

  • Clinical-stage oncology program advancement

    Advances oncology biologics candidates through clinical-stage development.

  • Process development

    Conducts process development activities at its Switzerland center of innovation.

  • Manufacturing

    Carries out manufacturing activities as part of its Switzerland-based operations.

What they work on

Modalities
Antibody, Bispecific
Therapeutic areas
oncology, hematological malignancies, solid tumors, multiple myeloma
Sites
New York, USA · La Chaux-de-Fonds, Switzerland · Neuchâtel, Switzerland · Lausanne, Switzerland
Team
Approximately 100 employees
Serves
global

Similar labs. 3C Therapeutics, Adragos Pharma, AGC Biologics, Alphalyse

Found in a contract services directory. Listing built from iginnovate.com. Work here? Claim this listing.

IGI · Midgard Science